I invested and worst investment decision of my life after 30 years of investing. Jacky not be Able to commercialise a dollar bill. Just keep burn cash and Co only kept alive by RD tax cash. Poor communication to market and keep avoid saying all 3 approved products not selling good. quartery revenue not even cover salary. She must be very embarrass in industry.
I agree Sarge- dep docetaxel is not good product or would have put out data of product alone, not keep doing more combinations. IMO only way it will get partnered is if jacky can get some company to take it as bundle with dep- capazitaxel. I not believe it ever get to market
DYOR.
SPL Price at posting:
70.0¢ Sentiment: None Disclosure: Held
